ArticleJapanese journal of clinical oncology2026
Triplet therapy with darolutamide and docetaxel for metastatic castration-sensitive prostate cancer: a multicenter real-world study.
Ibuki Tsuru et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.